What is AnaptysBio, Inc.'s AOCI?

AnaptysBio, Inc. (ANAB) reported AOCI of -$146K in Q1 2026.

How has AnaptysBio, Inc.'s AOCI changed year-over-year?

AnaptysBio, Inc.'s AOCI decreased by 190.7% year-over-year, from $161K to -$146K.

What is the long-term trend for AnaptysBio, Inc.'s AOCI?

Over 5 years (2020 to 2025), AnaptysBio, Inc.'s AOCI has grown at a 43.1% compound annual growth rate (CAGR), from -$4K to -$24K.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

AnaptysBio, Inc. ANAB AOCI

AOCI at other companies

Bristol-Myers SquibbBMY

-$1.37B+3.8%

Eli LillyLLY

-$2.83B+24.9%

PfizerPFE

-$7.2B+16.1%

AmgenAMGN

-$190M+17.7%

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

BiogenBIIB

-$140.2M+19.7%

Other financials

Income statement

See full

Revenue$25.6M-8.0%

Operating income-$34.6M-25.8%

Net income-$52.9M-34.5%

EPS (diluted)-$1.84-43.8%

Balance sheet

See full

Cash & equivalents$248.5M+152%

Total debt$13.6K-99.9%

Total equity$12.7M-62.5%

Total assets$329.7M-21.9%

Cash flow

See full

Operating cash flow-$25.9M-142%

CapEx$17.0K-51.4%

Free cash flow-$25.9M-142%

Valuation

See full

Market cap$1.73B+180%

Enterprise value$1.48B+176%

P/S7.4×+1.9×

Profitability

See full

Operating margin17.6%+9.6pp

Net margin-49.9%-22.6pp

FCF margin1.9%+1.0pp

Returns & leverage

See full

Return on equity-343.8%-1,012pp

Debt / equity0×-0.5×

Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AnaptysBio, Inc.'s AOCI?: AnaptysBio, Inc. (ANAB) reported AOCI of -$146K in Q1 2026.
How has AnaptysBio, Inc.'s AOCI changed year-over-year?: AnaptysBio, Inc.'s AOCI decreased by 190.7% year-over-year, from $161K to -$146K.
What is the long-term trend for AnaptysBio, Inc.'s AOCI?: Over 5 years (2020 to 2025), AnaptysBio, Inc.'s AOCI has grown at a 43.1% compound annual growth rate (CAGR), from -$4K to -$24K.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.